Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

Sell
50

AKRO
Akero Therapeutics

Last Price:
45.46
Seasonality Move:
1.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Akero Therapeutics Price Quote

$45.46

Akero Therapeutics Key Stats

Sell
50
Akero Therapeutics (AKRO) is a Sell

Day range:
$44.54 - $45.75
52-week range:
$7.52 - $48.24
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
14.22%

Volume:
496.8K
Avg. volume:
558.8K
1-year change:
122.52%
Market cap:
$2.1B
Revenue:
$0
EPS:
$-3.14

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Is Akero Therapeutics Cash Flow Positive?

  • What Is AKRO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$83.7M
  • What Is Akero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $35.3M
  • What Is Akero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $68.6M

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • Aeglea BioTherapeutics Inc (AGLE)
    • AVEO Pharmaceuticals Inc (AVEO)
    • Catalyst Pharmaceuticals Inc (CPRX)
    • 89bio Inc (ETNB)
    • Regeneron Pharmaceuticals Inc (REGN)

Akero Therapeutics Dividend Yield

Data Unavailable

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.51%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 50.33
Upside from Last Price: 10.72%

Major Shareholders

  • How many AKRO shares are owned by institutional investors?
    57.9M AKRO shares are owned by institutional investors
  • How many AKRO shares are owned by insiders?
    883.3K AKRO shares are owned by insiders